ArticlePloS one2026
Pheromone and morphometric features of honey bee (Apis mellifera) queens imported to Canada from around the globe.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canada imports approximately 300,000 honey bee queens annually to support the beekeeping industry, in addition to producing queens domestically during the short rearing season. Over 80% of imported queens come from the U.S., with additional contributions (~5% each) from Italy, Australia, and Chile. We conducted morphometric analysis and pheromone profiling of domestic and imported queens representing all four dominant exporting countries, including "vaccinated" (transgenerational immune-primed, or TGIP) and non-TGIP queens from the U.S., to compare their physical and pheromonal qualities. Imported queens differed morphometrically from domestic queens, and this difference was driven by smaller ovary size (a plastic metric exhibiting transient changes due to temporary confinement). Queen retinue pheromone (QRP) profiles also differed in domestic and imported queens, and PERMANOVA analysis showed that transit duration and ovary size were the top two explanatory factors. TGIP queens tended to have lower pheromone abundances than non-TGIP queens; a pattern that does not appear to be driven by pre-existing morphological differences. This study did not assess whether morphometric and pheromone differences affect acceptance rates or performance, nor whether immune priming offers benefits if pheromone discrepancies are enduring. By the measured laboratory metrics, domestic (Canadian) queens are comparable or better on several dimensions and investment in local production appears justified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.